ArticleCancer medicine2025

Tumor Regression Grade as a Predictor of Adjuvant Therapy Benefits in Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Therapy.

Yizhou Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.